Russell Angus C.

CIK 00015340027 companiesBRISBANE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001534002

Recent Transactions

50 trades

Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2025-07-01+75,000→ 75,000 total
Award
Structure Therapeutics Inc.$GPCR
Share Option (right to buy)
2025-06-23+42,833→ 42,833 total
Disposition to Issuer
Revance Therapeutics, Inc.
Common Stock
2025-02-06−15,000→ 0 total
Disposition from Tender
Revance Therapeutics, Inc.
Common Stock
2025-02-04$3.65/sh−36,506→ 15,000 total
Award
Structure Therapeutics Inc.$GPCR
Share option (right to buy)
2024-08-26+75,000→ 75,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2024-07-01+75,000→ 75,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2024-05-01+23,458→ 23,458 total
Award
Revance Therapeutics, Inc.
Common Stock
2024-05-01+15,000→ 51,506 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2023-07-01+50,000→ 50,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2023-05-03+3,534→ 36,506 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2023-05-03+5,915→ 5,915 total
Award
TherapeuticsMD, Inc.$TXMD
Restricted Stock Units
2022-09-29+5,000→ 5,000 total
Exercise/Conversion
TherapeuticsMD, Inc.$TXMD
Restricted Stock Units
2022-08-18−1,984→ 0 total
Exercise/Conversion
TherapeuticsMD, Inc.$TXMD
Common Stock
2022-08-18+1,984→ 5,792 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (right to buy)
2022-07-01+50,000→ 50,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+11,343→ 11,343 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 total
Award
Revance Therapeutics, Inc.
Common Stock
2022-05-04+6,059→ 32,972 total
Purchase
Revance Therapeutics, Inc.
Common Stock
2021-12-13$15.74/sh+6,400→ 26,913 total
Exercise/Conversion
TherapeuticsMD, Inc.$TXMD
Common Stock
2021-08-10+96,864→ 190,364 total
Exercise/Conversion
TherapeuticsMD, Inc.$TXMD
Restricted Stock Units
2021-08-10−96,864→ 0 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (right to buy)
2021-07-01+50,000→ 50,000 total
Award
TherapeuticsMD, Inc.$TXMD
Restricted Stock Units
2021-07-01+99,174→ 99,174 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-06-29$2.20/sh+24,720→ 92,220 total
Sale
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2021-06-29$2.97/sh−4,720→ 87,500 total
Exercise/Conversion
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (right to buy)
2021-06-29−24,720→ 0 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-05-05+4,013→ 20,513 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2021-05-05+7,551→ 7,551 total
Sale
Keenova Therapeutics plc
Ordinary Shares
2020-11-12$0.13/sh−51,789→ 0 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2020-07-01+40,000→ 40,000 total
Award
TherapeuticsMD, Inc.$TXMD
Restricted Stock Units
2020-06-18+96,864→ 96,864 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2020-05-14+12,000→ 12,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-05-14+6,000→ 16,500 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2020-05-13$2.96/sh−12,042→ 51,789 total
Purchase
TherapeuticsMD, Inc.$TXMD
Common Stock
2019-08-23$2.77/sh+10,000→ 93,500 total
Purchase
TherapeuticsMD, Inc.$TXMD
Common Stock
2019-08-15$2.99/sh+10,000→ 83,500 total
Purchase
TherapeuticsMD, Inc.$TXMD
Common Stock
2019-08-14$2.76/sh+25,000→ 73,500 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Stock Option (Right to Buy)
2019-07-01+40,000→ 40,000 total
Award
TherapeuticsMD, Inc.$TXMD
Non-Qualified Stock Option (right to buy)
2019-06-20+75,000→ 75,000 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2019-05-15$15.21/sh−11,764→ 37,072 total
Award
Keenova Therapeutics plc
Ordinary Shares
2019-05-15+26,759→ 63,831 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2019-05-09+9,000→ 9,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2019-05-09+4,500→ 10,500 total
Award
TherapeuticsMD, Inc.$TXMD
Non-Qualified Stock Option (right to buy)
2018-07-02+50,000→ 50,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2018-07-01+40,000→ 40,000 total
Award
Keenova Therapeutics plc
Ordinary Shares
2018-05-16+26,141→ 48,836 total
Award
Revance Therapeutics, Inc.
Common Stock
2018-05-10+3,000→ 6,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2018-05-10+6,000→ 6,000 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2018-03-01$15.68/sh−2,576→ 22,695 total
Tax Payment
Keenova Therapeutics plc
Ordinary Shares
2017-10-01$37.37/sh−476→ 25,271 total

Russell Angus C.

Recent Transactions

Companies

Recent Filings

Address